KVUE vs WMT
KVUE: The world's largest pure-play consumer health company, leveraging a portfolio of iconic brands like Tylenol, Listerine, and Neutrogena across self-care, skin health, and essential health categories. WMT: Global retail giant leveraging omnichannel integration, membership programs, and data-driven services to compete across groceries, general merchandise, and emerging high-margin business lines.
Side-by-side fundamentals
| Metric | KVUE | WMT | Edge |
|---|---|---|---|
| Price as of 2026-07-09 close | $19.18 | $113.10 | |
| Market cap as of 2026-07-10 | $36.8B | $896.1B | |
| P/E as of 2026-07-10 | 22.70 | 39.41 | KVUE lower |
| PEG as of 2026-07-10 | 2.72 | 4.30 | KVUE lower |
| Net margin as of 2026-07-10 | +10.6% | +3.1% | KVUE higher |
| Gross margin as of 2026-07-10 | +58.9% | +25.0% | KVUE higher |
| Operating margin as of 2026-07-10 | +17.1% | +4.2% | KVUE higher |
| ROE as of 2026-07-10 | +15.2% | +23.9% | WMT higher |
| ROA as of 2026-07-10 | +6.0% | +8.0% | WMT higher |
| Debt / equity as of 2026-07-10 | 0.82 | 0.62 | WMT lower |
| Revenue growth (YoY) as of 2026-07-10 | -0.1% | +5.9% | WMT higher |
| Revenue CAGR (3y) SEC XBRL | +0.2% | +5.3% | WMT higher |
| Dividend yield as of 2026-07-10 | +4.3% | +0.8% | KVUE higher |
| Dividend streak (yrs) SEC XBRL | 3 | 5 | WMT higher |
| Beta as of 2026-07-10 | 0.45 | 0.61 | |
| 1-year return as of 2026-07-09 close | -6.8% | +16.5% | WMT higher |
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.